content

Curing Cholestatic Liver Disease After Cognitive Impairment

Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems. There is presently no known...

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations

PHASTAR, aย global specialist biometrics contract research organization (CRO), has joined Lean Life Scienceโ€™s Oncology Development Programme (ODP2). The targeted programme aims to identify and...

3D COF Shows Good Hydrogen, CO2, And Methane Adsorption

In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework (COF) having a scu-c...

Top Biopharma Companies Show A Dip In Market Cap For Q3

The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in...

EMA Advocates For Recall of Pholcodine Drugs From EU Market

PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and children as well as...

Inizio acquires Evolution Road, bolstering Evokeโ€™s digital innovation and omnichannel offering

Inizio, a strategic partner for companies in health and life sciences, has today announced the acquisition of Evolution Road, a digital innovation company in...

Anaqua and PatSnap Team Up to Deliver an End-to-End Pharma IP Management Solution

Anaqua, the leading provider of innovation and intellectual property management technology, announced it is partnering with innovation intelligence platform PatSnap. The collaboration will deliver...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read